PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor

Peptide nucleic acid scaffolds represent a promising tool to interrogate the multivalent effects of ligand binding to a membrane receptor. Dopamine D2 receptors (D2R) are a class of G-protein coupled receptors (GPCRs), and the formation of higher-ordered structures of these receptors has been associ...

Full description

Saved in:
Bibliographic Details
Published in:ACS medicinal chemistry letters 2015-04, Vol.6 (4), p.425-429
Main Authors: Dix, Andrew V, Conroy, Jennie L, George Rosenker, Kara M, Sibley, David R, Appella, Daniel H
Format: Article
Language:English
Subjects:
Letter
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 429
container_issue 4
container_start_page 425
container_title ACS medicinal chemistry letters
container_volume 6
creator Dix, Andrew V
Conroy, Jennie L
George Rosenker, Kara M
Sibley, David R
Appella, Daniel H
description Peptide nucleic acid scaffolds represent a promising tool to interrogate the multivalent effects of ligand binding to a membrane receptor. Dopamine D2 receptors (D2R) are a class of G-protein coupled receptors (GPCRs), and the formation of higher-ordered structures of these receptors has been associated with the progression of several neurological diseases. In this Letter, we describe the synthesis of a library of ligand-modified PNAs bearing a known D2R agonist, (±)-PPHT. The D2R activity for each construct was assessed, and the multivalent effects were evaluated.
doi_str_mv 10.1021/ml500478m
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4394337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1674689763</sourcerecordid><originalsourceid>FETCH-LOGICAL-a246m-81515a1718933b8278c354cb9c282c5642037932308349d6eecfc6a83e6c0bf73</originalsourceid><addsrcrecordid>eNpVUclOwzAQtRCIQuHAD6BckLgEvC8XpFBWqSxiOVuO49BUzkKcVOLvSdVSldM8zTy9NzMPgBMELxDE6LL0DEIqZLkDDpCiMmZSsN0tPAKHIcwh5EoIuA9GmElFIKUHIHl9TuJrE1wWPfW-KxbGu6qL3q3J89pnIUrsstm5qJu56KZuTFlUA8DRm7Ou6er2COzlxgd3vK5j8Hl3-zF5iKcv94-TZBobTHkZS8QQM0igwZmkEgtpCaM2VRZLbBmnGBKhCCZQEqoy7pzNLTeSOG5hmgsyBlcr3aZPS5fZYc3WeN20RWnaH12bQv-fVMVMf9ULTYmihCwFztcCbf3du9DpsgjWeW8qV_dBIy4ol0pwMlBPt702Jn9_GwhnK4KxQc_rvq2G0zWCepmH3uRBfgH4ZHk_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1674689763</pqid></control><display><type>article</type><title>PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><source>PubMed Central</source><creator>Dix, Andrew V ; Conroy, Jennie L ; George Rosenker, Kara M ; Sibley, David R ; Appella, Daniel H</creator><creatorcontrib>Dix, Andrew V ; Conroy, Jennie L ; George Rosenker, Kara M ; Sibley, David R ; Appella, Daniel H</creatorcontrib><description>Peptide nucleic acid scaffolds represent a promising tool to interrogate the multivalent effects of ligand binding to a membrane receptor. Dopamine D2 receptors (D2R) are a class of G-protein coupled receptors (GPCRs), and the formation of higher-ordered structures of these receptors has been associated with the progression of several neurological diseases. In this Letter, we describe the synthesis of a library of ligand-modified PNAs bearing a known D2R agonist, (±)-PPHT. The D2R activity for each construct was assessed, and the multivalent effects were evaluated.</description><identifier>ISSN: 1948-5875</identifier><identifier>EISSN: 1948-5875</identifier><identifier>DOI: 10.1021/ml500478m</identifier><identifier>PMID: 25893044</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Letter</subject><ispartof>ACS medicinal chemistry letters, 2015-04, Vol.6 (4), p.425-429</ispartof><rights>Copyright © 2015 U.S. Government</rights><rights>Copyright © 2015 U.S. Government 2015 U.S. Government</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394337/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394337/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25893044$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dix, Andrew V</creatorcontrib><creatorcontrib>Conroy, Jennie L</creatorcontrib><creatorcontrib>George Rosenker, Kara M</creatorcontrib><creatorcontrib>Sibley, David R</creatorcontrib><creatorcontrib>Appella, Daniel H</creatorcontrib><title>PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor</title><title>ACS medicinal chemistry letters</title><addtitle>ACS Med. Chem. Lett</addtitle><description>Peptide nucleic acid scaffolds represent a promising tool to interrogate the multivalent effects of ligand binding to a membrane receptor. Dopamine D2 receptors (D2R) are a class of G-protein coupled receptors (GPCRs), and the formation of higher-ordered structures of these receptors has been associated with the progression of several neurological diseases. In this Letter, we describe the synthesis of a library of ligand-modified PNAs bearing a known D2R agonist, (±)-PPHT. The D2R activity for each construct was assessed, and the multivalent effects were evaluated.</description><subject>Letter</subject><issn>1948-5875</issn><issn>1948-5875</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVUclOwzAQtRCIQuHAD6BckLgEvC8XpFBWqSxiOVuO49BUzkKcVOLvSdVSldM8zTy9NzMPgBMELxDE6LL0DEIqZLkDDpCiMmZSsN0tPAKHIcwh5EoIuA9GmElFIKUHIHl9TuJrE1wWPfW-KxbGu6qL3q3J89pnIUrsstm5qJu56KZuTFlUA8DRm7Ou6er2COzlxgd3vK5j8Hl3-zF5iKcv94-TZBobTHkZS8QQM0igwZmkEgtpCaM2VRZLbBmnGBKhCCZQEqoy7pzNLTeSOG5hmgsyBlcr3aZPS5fZYc3WeN20RWnaH12bQv-fVMVMf9ULTYmihCwFztcCbf3du9DpsgjWeW8qV_dBIy4ol0pwMlBPt702Jn9_GwhnK4KxQc_rvq2G0zWCepmH3uRBfgH4ZHk_</recordid><startdate>20150409</startdate><enddate>20150409</enddate><creator>Dix, Andrew V</creator><creator>Conroy, Jennie L</creator><creator>George Rosenker, Kara M</creator><creator>Sibley, David R</creator><creator>Appella, Daniel H</creator><general>American Chemical Society</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150409</creationdate><title>PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor</title><author>Dix, Andrew V ; Conroy, Jennie L ; George Rosenker, Kara M ; Sibley, David R ; Appella, Daniel H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a246m-81515a1718933b8278c354cb9c282c5642037932308349d6eecfc6a83e6c0bf73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Letter</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dix, Andrew V</creatorcontrib><creatorcontrib>Conroy, Jennie L</creatorcontrib><creatorcontrib>George Rosenker, Kara M</creatorcontrib><creatorcontrib>Sibley, David R</creatorcontrib><creatorcontrib>Appella, Daniel H</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dix, Andrew V</au><au>Conroy, Jennie L</au><au>George Rosenker, Kara M</au><au>Sibley, David R</au><au>Appella, Daniel H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor</atitle><jtitle>ACS medicinal chemistry letters</jtitle><addtitle>ACS Med. Chem. Lett</addtitle><date>2015-04-09</date><risdate>2015</risdate><volume>6</volume><issue>4</issue><spage>425</spage><epage>429</epage><pages>425-429</pages><issn>1948-5875</issn><eissn>1948-5875</eissn><abstract>Peptide nucleic acid scaffolds represent a promising tool to interrogate the multivalent effects of ligand binding to a membrane receptor. Dopamine D2 receptors (D2R) are a class of G-protein coupled receptors (GPCRs), and the formation of higher-ordered structures of these receptors has been associated with the progression of several neurological diseases. In this Letter, we describe the synthesis of a library of ligand-modified PNAs bearing a known D2R agonist, (±)-PPHT. The D2R activity for each construct was assessed, and the multivalent effects were evaluated.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>25893044</pmid><doi>10.1021/ml500478m</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1948-5875
ispartof ACS medicinal chemistry letters, 2015-04, Vol.6 (4), p.425-429
issn 1948-5875
1948-5875
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4394337
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list); PubMed Central
subjects Letter
title PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T17%3A37%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PNA-Based%20Multivalent%20Scaffolds%20Activate%20the%20Dopamine%20D2%20Receptor&rft.jtitle=ACS%20medicinal%20chemistry%20letters&rft.au=Dix,%20Andrew%20V&rft.date=2015-04-09&rft.volume=6&rft.issue=4&rft.spage=425&rft.epage=429&rft.pages=425-429&rft.issn=1948-5875&rft.eissn=1948-5875&rft_id=info:doi/10.1021/ml500478m&rft_dat=%3Cproquest_pubme%3E1674689763%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a246m-81515a1718933b8278c354cb9c282c5642037932308349d6eecfc6a83e6c0bf73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1674689763&rft_id=info:pmid/25893044&rfr_iscdi=true